Massmutual Trust CO Fsb Eye Point Pharmaceuticals, Inc. Transaction History
Massmutual Trust CO Fsb
- $3.48 Billion
- Q3 2024
A detailed history of Massmutual Trust CO Fsb transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 65 shares of EYPT stock, worth $780. This represents 0.0% of its overall portfolio holdings.
Number of Shares
65
Previous 107
39.25%
Holding current value
$780
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding EYPT
# of Institutions
156Shares Held
57.5MCall Options Held
224KPut Options Held
1.41M-
Cormorant Asset Management, LP Boston, MA8.33MShares$99.9 Million5.57% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.18MShares$62.1 Million1.88% of portfolio
-
Franklin Resources Inc San Mateo, CA4.01MShares$48.1 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$45.2 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.59MShares$43.1 Million0.06% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $409M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...